After Reverse On Hydroxychloroquine Export Ban, India Says 'Only Meeting The Demand'

NPR | By Lauren Frayer

Published April 9, 2020 at 11:39 AM MDT

Facebook
Twitter
LinkedIn
Email

After President Trump complained, India reversed its export ban on the anti-malaria drug, which Trump has touted as a coronavirus treatment. There's no clinical evidence it works against COVID-19.

NPR Coronavirus Updates

Facebook
Twitter
LinkedIn
Email

Lauren Frayer

Lauren Frayer covers India for NPR News. In June 2018, she opened a new NPR bureau in India's biggest city, its financial center, and the heart of Bollywood—Mumbai.

See stories by Lauren Frayer